Dung-Tsa Chen
Overview
Explore the profile of Dung-Tsa Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
128
Citations
3082
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Park M, Zaw T, Yoder S, Gomez M, Genilo-Delgado M, Basinski T, et al.
G3 (Bethesda)
. 2022 Dec;
13(2).
PMID: 36454217
Intraductal papillary mucinous neoplasms (IPMNs) are precursor lesions to pancreatic ductal adenocarcinoma that are challenging to manage due to limited imaging, cytologic, and molecular markers that accurately classify lesions, grade...
22.
Aquino-Acevedo A, Knochenhauer H, Castillo-Ocampo Y, Ortiz-Leon M, Rivera-Lopez Y, Morales-Lopez C, et al.
Brain Behav Immun Health
. 2022 Nov;
26:100558.
PMID: 36439058
Mounting evidence suggests that chronic stress and subsequent distress can promote ovarian cancer progression. These altered psychological states have been linked to sustained release of stress hormones, activation of the...
23.
Kim S, Wuthrick E, Blakaj D, Eroglu Z, Verschraegen C, Thapa R, et al.
Lancet
. 2022 Sep;
400(10357):1008-1019.
PMID: 36108657
Background: Merkel cell carcinoma is among the most aggressive and lethal of primary skin cancers, with a high rate of distant metastasis. Anti-programmed death receptor 1 (anti-PD-1) and programmed death...
24.
Permuth J, Mesa T, Williams S, Cardentey Y, Zhang D, Pawlak E, et al.
Cancer Biomark
. 2022 May;
33(4):467-478.
PMID: 35491771
Background: Given the growing interest in using microRNAs (miRNAs) as biomarkers of early disease, establishment of robust protocols and platforms for miRNA quantification in biological fluids is critical. Objective: The...
25.
Permuth J, Rahman S, Chen D, Waterboer T, Giuliano A
J Pancreat Cancer
. 2021 Dec;
7(1):57-64.
PMID: 34901696
The association between () infection and pancreatic cancer (PC) risk remains inconclusive. We examined the association between antibodies and PC risk in a case-control study at a comprehensive cancer center....
26.
Saeed-Vafa D, Marchion D, McCarthy S, Hakam A, Lopez A, Wenham R, et al.
PLoS One
. 2021 Nov;
16(11):e0256615.
PMID: 34813586
Loss of stromal caveolin-1 (Cav-1) is a biomarker of a cancer-associated fibroblast (CAF) phenotype and is related to progression, metastasis, and poor outcomes in several cancers. The objective of this...
27.
Creelan B, Wang C, Teer J, Toloza E, Yao J, Kim S, et al.
Nat Med
. 2021 Aug;
27(8):1410-1418.
PMID: 34385708
Adoptive cell therapy using tumor-infiltrating lymphocytes (TILs) has shown activity in melanoma, but has not been previously evaluated in metastatic non-small cell lung cancer. We conducted a single-arm open-label phase...
28.
Permuth J, Vyas S, Li J, Chen D, Jeong D, Choi J
Front Oncol
. 2021 Aug;
11:712950.
PMID: 34367997
Background: Significant racial disparities in pancreatic cancer incidence and mortality rates exist, with the highest rates in African Americans compared to Non-Hispanic Whites and Hispanic/Latinx populations. Computer-derived quantitative imaging or...
29.
Chen D, Chan W, Thompson Z, Thapa R, Beg A, Saltos A, et al.
PLoS One
. 2021 Jul;
16(7):e0252041.
PMID: 34197475
Rationale: Recent studies have discovered several unique tumor response subgroups outside of response classification by Response Evaluation Criteria for Solid Tumors (RECIST), such as mixed response and oligometastasis. These subtypes...
30.
Permuth J, Dezsi K, Vyas S, Ali K, Basinski T, Utuama O, et al.
Cancers (Basel)
. 2021 Mar;
13(4).
PMID: 33671939
: Well-annotated, high-quality biorepositories provide a valuable platform to support translational research. However, most biorepositories have poor representation of minority groups, limiting the ability to address health disparities. : We...